Robert J. Hugin
Chairman and CEO, Celgene Corporation

Mr. Hugin serves as Chairman and Chief Executive Officer of Celgene Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory disease.  He joined Celgene in June 1999 and has been a Director of Celgene since December 2001.  Mr. Hugin also serves as a Director of The Medicines Company, Atlantic Health System, Inc. and of Family Promise, a national non-profit network assisting homeless families. He serves as Chairman of The Pharmaceutical Research and Manufacturers of America and is a member of the Board of Trustees of The Darden Foundation, University of Virginia as well as a founding Board member of Choose NJ.  Prior to joining Celgene, Mr. Hugin was a Managing Director with J.P. Morgan & Co. Inc. Mr. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period.  Bob and his wife Kathy have three children and live in Summit, New Jersey.

Read Robert Hugin's Incoming Chairman's Remarks at PhRMA's 2013 Annual Meeting in San Diego. 

Health Care Innovation & US Economy: CNBC Interviews Incoming PhRMA Chairman Hugin. Watch the interview here.

Protecting U.S. Medical Innovation: A Call To Action From Celgene's CEO